Rev-Eyes
Rev-Eyes Brand names, Rev-Eyes Analogs
Rev-Eyes Brand Names Mixture
- No information avaliable
Rev-Eyes Chemical_Formula
C19H27N5
Rev-Eyes RX_link
No information avaliable
Rev-Eyes fda sheet
Rev-Eyes msds (material safety sheet)
Rev-Eyes Synthesis Reference
No information avaliable
Rev-Eyes Molecular Weight
325.451 g/mol
Rev-Eyes Melting Point
No information avaliable
Rev-Eyes H2O Solubility
Soluble
Rev-Eyes State
Solid
Rev-Eyes LogP
No information avaliable
Rev-Eyes Dosage Forms
Ophthalmic solution (eye drops, 0.5%); Ophthalmic powder for reconstitution (0.5%)
Rev-Eyes Indication
Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.
Rev-Eyes Pharmacology
Dapiprazole is an alpha-adrenergic blocking agent. It produces miosis by blocking the alpha-adrenergic receptors on the dilator muscle of the iris. Dapiprazole produces no significant action on ciliary muscle contraction and thus, there are no changes in the depth of the anterior chamber of the thickness of the lens. It does not alter the IOP either in normal eyes or in eyes with elevated IOP. The rate of pupillary constriction may be slightly slower in clients with brown irises than in clients with blue or green irises.
Rev-Eyes Absorption
Systemic absorption is negligible.
Rev-Eyes side effects and Toxicity
Oral LD50 is 1189—2100 mg/kg in mice, rats and rabbits.
Rev-Eyes Patient Information
Rev-Eyes Organisms Affected
Humans and other mammals
